Telehealth program results in clinically significant weight loss

A telehealth-based weight loss program utilizing a health coach through video conferencing could result in clinically significant weight loss of over 5 percent of initial body weight in six months. Findings are published in the Journal of Telemedicine and Telecare.

In this study, researchers examined the effect of a telehealth weight loss program on assisting obese patients in losing a clinically significant amount of weight. A total of 25 obese participants were included in the study of the 12-week online program. All participants were given access to a platform for data tracking and video conferencing with the research team, but the intervention group had the additional opportunity to meet with a medical doctor once a month and with a dietitian weekly.

Results showed participants in the intervention group were able to lose a higher percentage of body weight than those in the control group. Additionally, clinically significant weight loss was achieved in 69.2 percent of intervention participants while only 8 percent of the control group achieved the same.

“Mobile phone-based health coaching may promote weight loss,” concluded first author Michelle Alencar, PhD, and colleagues. “Weekly video conferencing with education may be an applicable tool for inducing significant body weight loss in obese individuals.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.